$1.94
-0.120 (-5.83%)
At Close: Jun 03, 2026
Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment
08:00am, Tuesday, 23'rd Jul 2024
DALLAS, July 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI highlights concerns over stock manipulation
10:16am, Monday, 15'th Jul 2024
Spectral AI Inc (NASDAQ:MDAI) has updated stakeholders on its efforts to address potential market manipulation involving its common stock, primarily through naked short selling. The AI-driven medical
Spectral AI works with market leader on initial steps in Australia
10:03am, Monday, 08'th Jul 2024
Spectral AI Inc (NASDAQ:MDAI) said it will be assisted by a leading medical device company and burn wound therapy company in its application and potential deployment of its DeepView System for burn
DALLAS, July 08, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI adds two clinical trial sites to pivotal burn study
09:15am, Wednesday, 03'rd Jul 2024
Spectral AI Inc (NASDAQ:MDAI) announced that it has added two US clinical trial sites to its 2024 burn study, the University of California San Diego and the University of Utah. The medical diagnostics
Spectral AI Expands Clinical Trial Sites for Pivotal U.S. Burn Study
08:00am, Wednesday, 03'rd Jul 2024
DALLAS, July 03, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI achieves full pediatric enrollment in pivotal burn study
10:08am, Tuesday, 02'nd Jul 2024
Spectral AI Inc (NASDAQ:MDAI), a company specializing in AI-driven medical diagnostics, has announced the completion of pediatric patient enrollment for its 2024 pivotal study. The study aims to valid
Spectral AI Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study
08:00am, Tuesday, 02'nd Jul 2024
DALLAS, July 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI joins Russell Microcap Index
09:48am, Monday, 01'st Jul 2024
Spectral AI Inc (NASDAQ:MDAI), the wound care diagnostics specialist, has been included in the Russell Microcap Index following the annual Russell Reconstitution, which took effect after the market cl
Spectral AI Joins Russell Microcap® Index
08:00am, Monday, 01'st Jul 2024
DALLAS, July 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI near full enrollment of pediatric patients in burn study
09:07am, Thursday, 27'th Jun 2024
Spectral AI Inc (NASDAQ:MDAI) announced it surpassed 90% of its enrollment target for pediatric patients at burn centers for its late-stage study evaluating its AI-driven DeepView System. The company'
Spectral AI Surpasses 90% of Pediatric Enrollment Target in Burn Centers for Pivotal U.S. Burn Study
08:00am, Thursday, 27'th Jun 2024
DALLAS, June 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI supports naked short selling probe
08:37am, Monday, 24'th Jun 2024
Spectral AI Inc (NASDAQ:MDAI) told investors that it has provided support to Nasdaq and the state securities authorities in Florida, Louisiana and Texas to bring their attention to the potential marke
Spectral AI to Participate in the Northland Capital Markets Virtual Growth Conference
04:15pm, Monday, 17'th Jun 2024
DALLAS, June 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI reaches enrollment milestone for pivotal DeepView System study at US burn centers
11:02am, Thursday, 06'th Jun 2024
Spectral AI Inc (NASDAQ:MDAI) announced that it has achieved 50% clinical trial site enrollment for its pivotal Deepview System study. The DeepView System's image processing algorithm uses multispect
Sign In
Buy MDAI